Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. I
From MaRDI portal
Publication:2673008
DOI10.1016/j.jmaa.2022.126278zbMath1492.92041OpenAlexW4225123314MaRDI QIDQ2673008
Jianjun Paul Tian, Tuan Anh Phan
Publication date: 13 June 2022
Published in: Journal of Mathematical Analysis and Applications (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.jmaa.2022.126278
equilibrium manifoldvirotherapyinnate and adaptive immune responsesHopf bifurcation without parameters
Bifurcation theory for ordinary differential equations (34C23) Medical applications (general) (92C50)
Related Items (3)
Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. II ⋮ On a three-dimensional and two four-dimensional oncolytic viro-therapy models ⋮ DYNAMICAL BEHAVIORS OF A CLASS OF STOCHASTIC TUMOR–IMMUNE SYSTEMS
Cites Work
- Bifurcation without parameters
- Stochastic models for virus and immune system dynamics
- Modeling and analysis of a virus that replicates selectively in tumor cells
- ODE models for oncolytic virus dynamics
- The role of the innate immune system in oncolytic virotherapy
- Modeling of cancer virotherapy with recombinant measles viruses
- The replicability of oncolytic virus: defining conditions in tumor virotherapy
- Basic stochastic model for tumor virotherapy
- Mathematical and computational modeling for tumor virotherapy with mediated immunity
- Mathematical modeling of cancer radiovirotherapy
- Dynamics of tumor virotherapy: A deterministic and stochastic model approach
- Modeling with Itô Stochastic Differential Equations
- Modeling treatment of cancer using virotherapy with generalized logistic growth of tumor cells
- Dynamics of cholera epidemic models in fluctuating environments
- Modeling treatment of cancer using oncolytic virotherapy with saturated incidence
- Unnamed Item
- Unnamed Item
- Unnamed Item
This page was built for publication: Hopf bifurcation without parameters in deterministic and stochastic modeling of cancer virotherapy. I
